Journal List > Korean J Schizophr Res > v.17(2) > 1122198

Kim, Kim, Kim, Shim, Lee, and Ryu: A Case-Controlled Study of Cognitive Behavioral Therapy for Patients with Schizophrenia Having Violence-Related Crime

Abstract

Objectives

Despite remarkable development of pharmacotherapy for schizophrenia, some patients continuously have had violence problems. The violence of psychotic patients is recently becoming the focus of the attention. The aim of this study is to investigate the influence of Cognitive Behavioral Therapy (CBT) on patients with schizophrenia having violence related history.

Methods

15 Patients with schizophrenia spectrum disorder of crime history were treated with individual CBT for 12 sessions, and assessed with 4 scales (Korean version of Aggression Questionnaire, Korean version of the Barratt Impulsiveness Scale-11-Revised, Beck Cognitive Insight Scale and Positive and Negative Syndrome Scale) to evaluate anger, impulse, insight and clinical symptoms respectively at baseline and post treatment. The comparison group consisted of 15 patients with schizophrenia spectrum disorder of crime history. They were also assessed with the same scales during the same period.

Results

: Although impulsivity is not changed significantly after treatment, but there was significant improvement in clinical symptom, insight and aggression, especially self-reflectiveness and anger respectively.

Conclusion

: CBT can be one of the good therapeutic tools for patients with schizophrenia having violence problems in that it reduces aggression and enhances insight of patients with schizophrenia spectrum disorder.

References

1. McGlashan TH, Nayfack B. Psychotherapeutic models and the treatment of schizophrenia: the records of three successive psychotherapists with one patient at Chestnut Lodge for 18years. Psychiatry. 1988; 51:340–362.
2. Gunderson JG, Frank AF, Katz HM, Vannicelli ML, Frosch JP, Knapp PH. Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophr Bull. 1984; 10:564–598.
crossref
3. Hole RW, Rush AJ, Beck AT. A Cognitive investigation of schizophrenic delusions. Psychiatry. 1973; 42:312–319.
crossref
4. Tarrier N, Wittkowski A, Kinney C, McCarthy E, Morris J, Durability of the effects of cognitive-behavioral therapy in the treatment of chronic schizophrenia: 12month follow-up. Br J Psychiatry. 1999; 174:500–504.
5. Kuipers E, Fowler D, Garety P, Chisholm D, Freeman D, Dunn G, et al. London-east Anglia randomized controlled trial of cognitive-be-havioarl therapy for psychosis. III: follow-up and economic evaluation at 18months. Br J Psychiatry. 1998 Jul; 173:61–68.
6. Drury V, Birchwood M, Cochrane R. Cognitive therapy and recovery from acute psychosis: a controlled trial. 3. Five-year follow-up. Br J Psychiatry. 2000; 177:8–14.
7. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. Randomised controlled trial of cognitive-behavioral therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry Suppl. 2002; 43:s91–e97.
8. National Institute for Clinical Excellence. Clinical Guideline 1: Schizophrenia – Core Investigations in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: National Institute for Clinical Excellence;2010. p. 257–274.
9. Editorial. Increasing Crimes of Mental patients [serial online]. Mun-hwa.com;. 2014. Mar [cited 2014 Mar 3]; Available from URL:. http://www.munhwa.com/news/view.html?no=2014030301073137012002.
10. Jeon SY. ‘Mutjima Crime', Repeated Crime is 78% [serial online]. Chosun.com;2014 Jul [cited 2014 jul 16]; Available from URL:. http://news.chosun.com/site/data/html_dir/2014/07/16/2014071600260.html.
11. Kim KR, Lee SY, Kang JI, Kim BR, Choi SH, Park JY. Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultrahigh risk for psychosis. Early Interv Psychiatry. 2011; 5:174–178.
crossref
12. Lee DE, Lee HJ, Yoon OS, Choi IY, Jo JB, Kang KJ. The Effect of cognitive behavioral therapy in drug-resistant patients with schizophrenia. J Korean Neuropsychiatr Assoc. 2013; 52:26–32.
crossref
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. Washington, DC: American Psychiatric Press, Inc;2000.
14. Opler LA, Opler MG, Malaspina D. Reducing guesswork in schizophrenia treatment: PANSS can target and gauge therapy, predict outcomes. Current Psychiatry. 2006; 5:76–84.
15. Buss AH, Perry M. The aggression questionnaire, J Pers Soc Psychol. 1992; 63:252–259.
16. Kwon SM, Seo SG. Brief report: Validation study of the Korean version of the Aggression. Korean J Cinic Psych. 2002; 186:487–501.
17. Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophrenia R. 2004; 68:319–329.
crossref
18. Kim YR. A preliminary study for the development of the Korean version of the Beck Cognitive Insight Scale. Sungshin Women's Univ. 2006; 64:16–17.
19. Barratt ES. Anxiety and impulsiveness related to psychomotor efficiency. Percept Mot Skills. 1959; 9:191–198.
crossref
20. Lee SR, Lee WH, Park JS, Kim SM, Kim JW, Shim JH. The Study on Reliability and Validity of Korean Version of the Barratt Impulsiveness Scale-11-Revised in Nonclinical Adult Subjects. J Korean Neuropsychiatr Assoc. 2012; 51:378–386.
crossref
21. Jeon IH, Lee SY, Sun JY, Baek SY, Song YY, Ahn SG, et al, The Cognitive therapy for Schizophrenia. 1st ed.Seoul: HakJisa;2013. p. 1–354.
22. Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB. Wagner HR, Rosenheck RA, et al, A National Study of Violent Behavior in Persons with Schizophrenia. Arch Gen Psychiatry. 2006; 63:490–499.
23. Bobes J, Fillat O, Arango C. Violence among schizophrenia outpatient complaint with medication: prevalence and associated factors. Acta Psych Scand. 2009; 119:218–225.
24. Lysaker P, Bell M, Milstein R, Bryson G, Beam-Goulet J. Insight and psychological treatment compliance in Schizophrenia. Psychiatry. 1994; 57:307–315.
25. Arango C, Barda AC, Gonzalez-Salvador T, Ordonez AC. Violence in Inpatient with Schizophrenia. Schizophr bull. 1999; 25:493–503.
26. Lysaker P, Bell M. Insight and Cognitive Impairment in Schizophrenia performance on Repeated Administrations of the Wisconsin Card Sorting Test. J Nerv Ment Dis. 1994; 182:656–660.
crossref
27. Beck AT, Rector NA. Cognitive Approaches to Schizophrenia: Theory and Therapy. Annu Rev Clin Psychol. 2005. 577–606.
crossref
28. Brabban A, Tai S, Turkington D. Predictors of Outcome in Brief Cognitive Behavior Therapy for Schizophrenia, Schizophr Bull. 2009; 35:859–864.
29. Haddock G, Barrouwclough C, Shaw J, Dunn G, Novaco RW, Tarrier N. Cognitive behavioral therapy social activity therapy for people with psychosis and a history of violence: randomised controlled trial. Br J Psychiatry. 2009; 194:152–157.
30. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A Meta-Analysis of Cognitive remediation of Schizophrenia. Am J Psychiatry. 2007; 164:1791–802.

Table 1.
Type of Crimes: the treated and the non-treated group
  CBT (n=15) TAU (n=14)
Patricide or Matricide (%) 4 (26.7) 3 (21.4)
Attempted murder (%) 3 (20.0) 4 (28.6)
Arson (%) 3 (20.0) 2 (14.3)
Robbery or Assault (%) 5 (33.3) 5 (35.7)

CBT: Cognitive-behavioral therapy, TAU: Treatment as usual

Table 2.
Basic characteristics of the treated and non-treated group
Characteristic CBT (n=15) TAU (n=14) p
Sex (%) Age years SD 11 (73.0) 37.4 8.15 10 (71.4) 36.2 6.85 .913 .676
Age (years)(SD) 37.4 (8.15) 36.2 (6.85) .676
Education (years)(SD) 13.9 (2.55) 13 (2.79) .229
Age of onset (years)(SD) 25.2 (6.42) 26.4 (6.13) .603
Duration of illness (years)(SD) 12.3 (9.42) 9 (4.55) .131
Duration of admission (months)(SD) 15 (6.49) 16.2 (8.69) .736

CBT: Cognitive-behavioral therapy, TAU: Treatment as usual

Table 3.
Scores of baseline and post treatment for CBT and TAU group
    CBT (n=15) TAU (n=14) t p
M SD M SD
K-BIS-11-R Baseline 64.40 14.52 63.21 13.22 .229 .820
End point 62.07 16.80 61.85 10.26 .040 .968
BCIS Baseline 04.13 03.27 05.21 03.40 –.873 .391
End point 09.93 02.66 05.71 02.49 4.40 .000
K-AQ Baseline 65.73 19.26 64.57 13.67 .186 .854
End point 49.33 08.64 63.50 15.75 –2.18 .039
PANSS Baseline 65.60 13.17 73.00 17.38 –1.29 .205
End point 59.80 13.82 71.71 16.54 –2.11 .044

CBT: Cognitive-behavioral therapy, TAU: Treatment as usual, K-BIS-11-R: Korean version of the Barratt Impulsiveness Scale-11-Revised, BCIS: Beck Cognitive Insight Scale, K-AQ: the Aggression Questionnaire (Korean Version), PANSS: Positive and Negative Syndrome Scale

Table 4.
Subcategories of the Aggression Questionnaire (Korean Version)(K-AQ) of the Cognitive-behavioral therapy group
    M SD t p
Physical Baseline 19.26 6.49 3.914 .002
End point 16.20 5.10    
Verbal Baseline 13.26 3.83 4.002 .001
End point 10.27 2.31    
Anger Baseline 13.86 4.74 5.664 .000
End point 07.40 1.99    
Hostility Baseline 19.40 6.41 3.674 .003
End point 14.86 3.50    
Table 5.
Subcategories of the Beck Cognitive Insight Scale (BCIS) of the Cognitive-behavioral therapy group
    M SD t p
Self-reflectiveness Baseline 19.67 3.02 –6.48 .000
End point 24.13 3.99
Self-certainty Baseline 15.53 3.46 –2.96 .010
End point 14.33 3.58
TOOLS
Similar articles